← back to search

Hans‐Georg Kräusslich

Heidelberg University · DE
Area of research
Virology · Infectious Diseases
Research interest
Research interests include HIV Research and Treatment, HIV/AIDS drug development and treatment, Bacteriophages and microbial interactions, and Genetic and phenotypic traits in livestock.
h-index
87
citations
30,658
works
454
NIH funding
primary concept
Biology
email

Recent publications

Elevated Soluble ACE2 Activity in Children and Adults After SARS‐CoV‐2 Exposure Irrespective of Laboratory‐Confirmed Infection
Journal of Medical Virology 2024cited by 2position: middledoi
Evolution of SARS-CoV-2 in the Rhine-Neckar/Heidelberg Region 01/2021 – 07/2023
Infection Genetics and Evolution 2024cited by 2position: middledoi
Scalable RT‐LAMP‐based SARS‐CoV‐2 testing for infection surveillance with applications in pandemic preparedness
EMBO Reports 2023cited by 13position: middledoi
Live‐virus neutralization of the omicron variant in children and adults 14 months after SARS‐CoV‐2 wild‐type infection
Journal of Medical Virology 2023cited by 4position: middledoi
Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trial
Nature Cancer 2022cited by 62position: middledoi
Generation of Human Lung Organoid Cultures from Healthy and Tumor Tissue to Study Infectious Diseases
Journal of Virology 2022cited by 29position: middledoi
Waning Immunity 14 Months After SARS-CoV-2 Infection
PEDIATRICS 2022cited by 8position: middledoi
Anti-SARS-CoV-2 antibody containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19 via increased neutralizing antibody activity – a randomized clinical trial
medRxiv 2022cited by 4position: middledoi
Seroconversion Rates After the Second COVID-19 Vaccination in Patients With Systemic Light Chain (AL) amyloidosis
HemaSphere 2022cited by 1position: middledoi
Cone-shaped HIV-1 capsids are transported through intact nuclear pores
Cell 2021cited by 343position: middledoi
Humoral and cellular responses after COVID-19 vaccination in anti-CD20-treated lymphoma patients
Blood 2021cited by 88position: middledoi
The Abbott PanBio WHO emergency use listed, rapid, antigen-detecting point-of-care diagnostic test for SARS-CoV-2—Evaluation of the accuracy and ease-of-use
PLoS ONE 2021cited by 55position: middledoi
Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 in Households with Children, Southwest Germany, May–August 2020
Emerging infectious diseases 2021cited by 32position: middledoi
From Multiplex Serology to Serolomics—A Novel Approach to the Antibody Response against the SARS-CoV-2 Proteome
Viruses 2021cited by 22position: middledoi
Local emergence and decline of a SARS-CoV-2 variant with mutations L452R and N501Y in the spike protein
medRxiv 2021cited by 20position: middledoi
Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): study protocol for a two-factorial randomized controlled multi-arm trial with cluster sampling
Trials 2021cited by 6position: middledoi
Structures and distributions of SARS-CoV-2 spike proteins on intact virions
Nature 2020cited by 1,271position: middledoi
A colorimetric RT-LAMP assay and LAMP-sequencing for detecting SARS-CoV-2 RNA in clinical samples
Science Translational Medicine 2020cited by 701position: middledoi
SARS-CoV-2 RNA Extraction Using Magnetic Beads for Rapid Large-Scale Testing by RT-qPCR and RT-LAMP
Viruses 2020cited by 119position: middledoi
Benchmarking tomographic acquisition schemes for high-resolution structural biology
Nature Communications 2020cited by 86position: middledoi
Pre-arrayed Pan-AAV Peptide Display Libraries for Rapid Single-Round Screening
Molecular Therapy 2020cited by 75position: middledoi
NSs amyloid formation is associated with the virulence of Rift Valley fever virus in mice
Nature Communications 2020cited by 64position: middledoi
Microscopy‐based assay for semi‐quantitative detection of SARS‐CoV‐2 specific antibodies in human sera
BioEssays 2020cited by 36position: middledoi
Screening for SARS-CoV-2 infections with colorimetric RT-LAMP and LAMP sequencing
medRxiv 2020cited by 32position: middledoi
SARS-CoV-2 RNA extraction using magnetic beads for rapid large-scale testing by RT-qPCR and RT-LAMP
medRxiv 2020cited by 23position: middledoi
A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial
Trials 2020cited by 19position: middledoi
Microscopy-based assay for semi-quantitative detection of SARS-CoV-2 specific antibodies in human sera
bioRxiv (Cold Spring Harbor Laboratory) 2020cited by 9position: middledoi
McQ – An open-source multiplexed SARS-CoV-2 quantification platform
medRxiv 2020cited by 5position: middledoi
From multiplex serology to serolomics – a novel approach to the antibody response against the SARS-CoV-2 proteome
medRxiv 2020cited by 2position: middledoi
Clathrin-adaptor ratio and membrane tension regulate the flat-to-curved transition of the clathrin coat during endocytosis
Nature Communications 2018cited by 148position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Bárbara Müller · Heidelberg University12 papers (2013–2024)Ralf Bartenschlager · German Cancer Research Center9 papers (2013–2024)Paul Schnitzler · Heidelberg University8 papers (2020–2024)Kathleen Börner · European Molecular Biology Organization5 papers (2013–2024)Steeve Boulant · University of Florida4 papers (2017–2020)Susann Kummer · Robert Koch Institute4 papers (2017–2022)Claudius Speer · Heidelberg University4 papers (2021–2023)Janina Hanne · Deutsche Gesellschaft für Information und Wissen4 papers (2016–2017)Vojtěch Žíla · Heidelberg University3 papers (2016–2021)Ellen Wiedtke · University Hospital Heidelberg3 papers (2013–2020)Vladimı́r Beneš · European Molecular Biology Laboratory3 papers (2020–2024)Vibor Laketa · University Hospital Heidelberg3 papers (2017–2021)Kathrin Jeltsch · Heidelberg University3 papers (2022–2024)Dirk Grimm · Vector (United States)3 papers (2013–2020)Louise Benning · Nierenzentrum Heidelberg3 papers (2021–2023)Michael Knop · German Cancer Research Center3 papers (2020–2020)Tim Waterboer · German Cancer Research Center3 papers (2020–2022)Sven F. Garbade · Heidelberg University3 papers (2022–2024)Stefan W. Hell · Max Planck Institute for Medical Research3 papers (2015–2016)Georg F. Hoffmann · Heidelberg University3 papers (2022–2024)